Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis

Zhang, Tengfei; Cao, Ling; Xie, Jing; Shi, Ni; Zhang, Zhen; Luo, Zhenzhen; Yue, Dongli; Zhang, Zimeng; Wang, Liping; Han, Weidong; Xu, Zhongwei; Chen, Hu; Zhang, Yi

期刊名称Oncotarget
作者Zhang, Tengfei; Cao, Ling; Xie, Jing; Shi, Ni; Zhang, Zhen; Luo, Zhenzhen; Yue, Dongli; Zhang, Zimeng; Wang, Liping; Han, Weidong; Xu, Zhongwei; Chen, Hu; Zhang, Yi
卷第6卷
期第32期
电子ISSN1949-2553
文件大小3403.71KB
发表时间2015-10-20
DOI10.18632/oncotarget.5582

发现好书期刊，享受阅读乐趣

Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis